As COVID-19 began to spread around the world, Gilead employees worked around the clock to advance the company’s investigational antiviral.
In the next episode of our “Possible” series, meet Laura Bauer, a scientist in the company’s Formulation and Process Development group. Learn how she worked with her team, colleagues at Gilead, and partners across a wide manufacturing and supply chain network to expand production.
The partnership between TechsoMed and Lenovo is enabling physicians to target cancer with never before seen precision.
To treat cancerous tumors, physicians have long relied on surgery, chemotherapy and radiation — highly invasive treatments that push patients’ bodies to their limits. Surgically removing tumors requires long hospital stays, recovery times and extensive follow-ups. In the near future, all of this might change.
Dr. Zoltan Takacs uses a ThinkPad to analyze some of the world's deadliest toxins and turn them into medicine leads.
Most people avoid venomous creatures. Dr. Zoltan Takacs has spent his life chasing them.
The renowned scientist and explorer seeks out the venoms of some of the world’s deadliest creatures — snakes, spiders, scorpions and more — with the hope that their lethal toxins will provide a template for designing new medicines. The basic logic behind his method: What can kill you just might save your life.
Here are the top five things Medtronic learned from the pandemic and why we won’t forget.
When news of a mysterious, pneumonia-like disease spreading in China first broke in early 2020, few realized life was about to change for everyone. But that’s exactly what happened as cases of COVID-19 erupted everywhere and caused a global health pandemic.
Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained
NEW YORK, March 22, 2021 /3BL Media/-As the world begins to emerge from under the weight of multiple crises, investors are seeking more effective and efficient ESG (environment, social, governance) communications directly from companies, which include a longer-term strategy and vision.
Even as COVID-19 vaccinations ramp up across the United States, many Americans still struggle to find appointments. As President Biden adds to the pressure on states by directing them to make all adults eligible for the COVID-19 vaccine by May 1, the private sector is moving in to help. This week, we examine how brands are utilizing their resources and teaming up to work toward putting an end to the pandemic.
The speed at which COVID-19 vaccines have been developed and produced hasn’t been matched by society’s ability to administer doses. As of this writing, 30 million doses delivered in the US have yet to be administered.